Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

Summary

A phase II double blind trial to evaluate the effects of the AMPA, glutamte antagonist, topiramate on levodopa-induced dyskinesia in Parkinson's disease

Timeline

Start

2004-09

Primary completion

—

Completion

2007-03

Outcome

Outcome not reported

Stopped (Enrollment): “early termination due to slow recruitment”

Drugs

Indications